Ad is loading...
MENU
PTIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Protagenic Therapeutics (PTIX) Ownership - Who owns Protagenic Therapeutics?

Profile

Industry
N/A
Address
149 Fifth Avenue
Phone
+1 212 994-8200
Employees
3
Web
https://www.protagenic.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.97M
P/E Ratio
N/A
Total Cash
924.6K
Projected Growth
N/A
Total Debt
419.76K
Revenue
N/A
Risk (Beta)
1.11
Dividend Yield
N/A
Total Cash/Share
0.14
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

PTIX
Capitalization
3.97M
P/E Ratio
N/A
Risk (Beta)
1.11
Dividend Yield
N/A
Total Cash
925K
Total Cash/Share
0.14
Total Debt
420K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
793K
P/B Ratio
5.00
Cash Flow
N/A
Earnings
-1.45
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
447
Current Ratio
2.03
Current Revenue Per Employee
300634.16
Dividends Per Share - Security
N/A
EBITDA
-6.31M
Float
N/A
Float - Current
N/A
Gross Income Margin
-5.50
Revenue To Assets
-152.72
Shares Held By Institutions
172K
Shares Outstanding - Current
6.42M
Total Liabilities
675K
Total Volume MTD
N/A
Value
N/A
Gain YTD
-37.569
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
149 Fifth Avenue
Phone
+1 212 994-8200
Employees
3
Web
https://www.protagenic.com